Page 35 - IJB-6-3
P. 35

Shpichka, et al.
           Table 2. Possible fibrin modifications to tune its biological properties.

           Modifying agent           Type of IM    Type of experiments  Outcomes                          Ref.
           PLGA nanoparticles loaded   Physical    In vivo (diabetic mice)  Promoted wound closure        [46]
           with VEGF and bFGF                                          Accelerated re-epithelialization
                                                                       Increased formation of granulation
                                                                       tissue
                                                                       Enhanced collagen synthesis
           Platelet-like particles   Physical      In vitro            Promoted cell migration            [55]
                                                   In vivo (mice)      Improved wound healing
           TG-PDGF.AB                Covalent      In vivo (pigs)      Enhanced wound healing             [47]
           KGF                       Covalent      In vitro            Increased cell migration           [48]
                                                   In vivo (mice)      Improved wound healing
           RGD, IKVAV, YIGSR, and    Cocrosslinking In vitro (dorsal root   Enhanced neurite outgrowth    [56]
           RNIAEIIKDI                              ganglia dissected from
                                                   chicken embryos)
                                                   In vivo (rats)      Improved axons regeneration
           Bifunctional carboxylated   Covalent    In vitro            Maintained cell proliferation      [57]
           N-hydroxysulfosuccinimide-                                  Increased ALP activity
           active ester PEG                                            Up-regulated osteoblast-specific genes
                                                   In vivo (nude mice)  Formation of soft vascularized
                                                                       connective tissue
           O,O′-bis[2-(N-succinimidyl-  Covalent   In vitro (MSC       Promoted better sprouting          [58]
           succinylamino)ethyl]PEG                 spheroids)
           TG-VEGF121                Covalent      In vivo (VEGFR2-luc   Enhanced vessel formation        [59]
                                                   mice)               SMC stabilization
           Fusion proteins LN-TGF-β1   Covalent    In vitro            Enhanced contractile function of   [60]
           and LNG-TGF-β1                                              vascular constructs
           T1 peptide sequence from   Covalent     In vitro            Improved cellular sprouting without   [61]
           CCN1                                                        adding VEGF
                                                                       Increased effects when VEGF is added
                                                   In vivo (CAM)       Stimulated formation of new vessels
           Anti-VEGF aptamer and anti- Covalent    In vivo (mice)      Enhanced blood vessel growth       [62]
           PDGF-BB aptamer           Affinity
           TG-PDGF.AB                Covalent      In vivo (rats)      Decreased flap tissue necrosis     [63]
                                                                       Enhanced perfusion
                                                                       Maturation of new vessels
           Vector containing the     Physical      In vivo (rats)      Prolonged flap survival for 7 days after   [64]
           VEGF-A cDNA                                                 surgery

                                                                       Increased perfusion of tissues

                                                                       Higher VEGF-A expression
           Abbreviations. Ref: References; ALP: Alkaline phosphatase activity; bFGF: Basic fibroblast growth factor; CAM: Chorioallantoic membrane; IM: Immobilization; KGF: Keratinocyte
           growth factor; MSC: Mesenchymal stromal cells; PDGF: Platelet-derived growth factor; PEG: Polyethylene glycol; PLGA: Poly(lactic-co-glycolic acid); SMC: Smooth muscle
           cells; TG: Transglutaminase; TGF-β: Transforming growth factor beta; VEGF: Vascular endothelial growth factor
           improvement of wound healing in severe burns .        Except  pure  fibrin  and  the  mentioned  above
                                                        [47]
           Muhamed  et al.   fabricated  fibrin  nanoparticles,   modifications,  there  is  also  platelet-rich  fibrin
                          [48]
           which  were  modified  with  keratinocyte  growth   (PRF) that is so-called  the “second-generation
           factor (KGF) by its coupling using carbodiimide    platelet concentrate” . This review does not go
                                                                                   [49]
           derivative  and  N-hydroxysulfosuccinimide.  These   into  details  regarding  this  type  of  fibrin-based
           particles  had  higher  healing  potential  that  those   products. The reader can learn more about it from
           from non-loaded ones.                              the following publications [49-54] .


                                       International Journal of Bioprinting (2020)–Volume 6, Issue 3        31
   30   31   32   33   34   35   36   37   38   39   40